Abstract |
In 26 patients with plasmocytoma and 4 patients with benign monoclonal gammopathy bone marrow scintigraphy using 99mTc-labelled monoclonal antigranulocyte- antibodies was performed. Focal marrow defects were found in 18/26 patients with plasmocytoma but in none with benign monoclonal gammopathy. The results in plasmocytoma patients correlated well with the clinical staging system of Durie and Salmon. Quantification showed a suppressed bone marrow uptake ratio in 8/26 patients. A marked bone marrow expansion was present in only 2/26 patients. Bone marrow scintigraphy seems to be a valuable diagnostic tool in patients with plasmocytoma, especially as it is able to visualize the degree of bone marrow infiltration in a single protocol and so allows to follow up patients in a simple noninvasive manner.
|
Authors | J Bathmann, W Brugger, C Ullrich, R Mertelsmann, E Moser |
Journal | Nuklearmedizin. Nuclear medicine
(Nuklearmedizin)
Vol. 34
Issue 2
Pg. 66-70
(Apr 1995)
ISSN: 0029-5566 [Print] Germany |
Vernacular Title | Immunszintigraphie des Knochenmarks beim Plasmozytom. |
PMID | 7761276
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Technetium
|
Topics |
- Antibodies, Monoclonal
- Bone Marrow
(diagnostic imaging)
- Diagnosis, Differential
- Humans
- Neoplasm Staging
- Paraproteinemias
(diagnostic imaging)
- Plasmacytoma
(diagnostic imaging, pathology)
- Radioimmunodetection
(methods)
- Technetium
|